BPOM Reveals Challenges Facing Indonesia's Jamu Industry

Jakarta, CNBC Indonesia - BPOM Deputy Head of the Traditional Medicine, Health Supplements, and Food Supervision Division, Mohamad Kashuri, has disclosed the challenges facing Indonesia’s jamu industry. He stated that Indonesia’s jamu industry faces numerous complex challenges from upstream to downstream, including regulatory issues. According to him, most players in the jamu industry, not only large enterprises but also micro, small, and medium enterprises (MSMEs), lack understanding of regulations. ‘So they naturally face obstacles during regulatory compliance or marketing,’ he said at the Health Forum on Tuesday, 26 May 2026. Additionally, he noted that another issue facing the industry is capital. Capital is deemed crucial for driving the jamu business, particularly for MSMEs. He explained that many Indonesian jamu MSMEs lack sufficient capital, hindering their business expansion efforts. Next is the production aspect. Kashuri said industry players require high-quality, standardised raw materials. However, jamu raw materials are largely imported. ‘This also poses challenges for MSMEs. Furthermore, product innovation is another hurdle—developing effective products with appealing packaging. Marketing also remains a challenge. How can jamu contribute to economic growth? There are many complex issues,’ he explained. BPOM, as a government agency mandated under Presidential Regulation No. 80 of 2017, consistently implements food and drug supervision policies. BPOM’s role includes product evaluation before market release and ongoing monitoring to ensure safety, quality, and efficacy. ‘Merely one point: jamu development requires collaboration among various stakeholders to address these issues,’ he concluded.